Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Homoarginine in Stroke (HiS) Study

NCT03692234 is registered in ClinicalTrials.gov with Universitätsklinikum Hamburg-Eppendorf as lead sponsor.

NCT NCT03692234
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03692234 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Homoarginine in Stroke (HiS) Study
Lead sponsor
Universitätsklinikum Hamburg-Eppendorf
Phase
Not applicable
Overall status
Unknown status
Start date
August 22, 2018
Completion date
August 31, 2023
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

deficiency; diet